GlassScriptPhysician profile
Christopher James Leslie
NPI 1922012772
$92,723.89
in general payments reported to CMS, 2019-2025
11 companies · $80.82 in 2025
The $80.82 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $26K · 2021: $25K · 2022: $181 · 2023: $695 · 2024: $157 · 2025: $80.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $86,621.06 | 2019-2021 | |
| Tracpatch Health, INC | $4,272.20 | 2019 | |
| Stryker Corporation | $865.52 | 2019-2024 | Gamma, Variax |
| Uoc USA INC | $369.77 | 2022-2023 | U2, Conformity, U-Motion II and Ustar II |
| Depuy Synthes Sales INC. | $289.30 | 2020-2025 | Tfn-Advance, Motoband, Va-Lcp |
| Heraeus Medical, LLC. | $107.09 | 2023 | Palacos |
| Pacira Pharmaceuticals Incorporated | $82.97 | 2019 | |
| Pylant Medical | $43.09 | 2023-2025 | |
| Ethicon US, LLC | $39.37 | 2022 | |
| Bioventus LLC | $17.11 | 2023 | Durolane |
| Medtronic USA, INC. | $16.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,753.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Leslie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.